{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T13:29:14Z","timestamp":1775827754545,"version":"3.50.1"},"reference-count":30,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Chronic kidney disease (CKD) is associated with increased cardiovascular morbidity and mortality, even at early stages. Postmenopausal women represent a particularly vulnerable population due to estrogen deficiency, which promotes adverse cardiovascular remodeling. However, data specifically characterizing the cardiac phenotype of hypertensive postmenopausal women with mild-to-moderate CKD remain limited. Methods: We conducted a prospective observational cohort study including 413 hypertensive postmenopausal women consecutively referred to a tertiary center between 2019 and 2022. Participants were stratified into a CKD group with stage 3 CKD (estimated glomerular filtration rate of 30\u201359 mL\/min\/1.73 m2; n = 213) and a control group without CKD (n = 200). All subjects underwent comprehensive clinical evaluation, laboratory testing, and standardized transthoracic echocardiography. The prevalence of left ventricular hypertrophy (LVH), left ventricular diastolic dysfunction (LVDD), and chronic coronary syndromes (CCS) was assessed. Multivariable logistic regression analyses were performed to evaluate independent associations between CKD and cardiovascular abnormalities. Results: Compared with controls, women with CKD showed a significantly higher prevalence of LVH (46.7% vs. 21.5%), LVDD (55.8% vs. 36.0%), and CCS (15.5% vs. 7.5%) (all p &lt; 0.01). The coexistence of LVH and LVDD identified a high-risk cardiac phenotype that was markedly more frequent in the CKD group (41.3% vs. 12.5%). After adjustment for age, body mass index, blood pressure, duration of hypertension, smoking status, and antihypertensive therapy, stage 3 CKD remained independently associated with LVH, LVDD, and CCS. Conclusions: In hypertensive postmenopausal women, mild-to-moderate CKD is associated with a substantial burden of cardiac structural and functional abnormalities exceeding that attributable to hypertension alone, supporting early cardiovascular screening and an integrated cardiorenal approach.<\/jats:p>","DOI":"10.3390\/jcm15082895","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:01:52Z","timestamp":1775822512000},"page":"2895","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Blood Pressure: Cardiac Structural and Functional Abnormalities in Hypertensive Postmenopausal Women with Mild-to-Moderate Chronic Kidney Disease"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8285-1623","authenticated-orcid":false,"given":"Pasquale","family":"Palmiero","sequence":"first","affiliation":[{"name":"Cardiology Equipe, ASL Brindisi, 72100 Brindisi, Italy"},{"name":"Medical School, University of Bari, 70122 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7101-7701","authenticated-orcid":false,"given":"Francesca","family":"Amati","sequence":"additional","affiliation":[{"name":"University Cardiology Unit, Interdisciplinary Department of Medicine, Polyclinic University Hospital, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucrezia","family":"Bombini","sequence":"additional","affiliation":[{"name":"University Cardiology Unit, Interdisciplinary Department of Medicine, Polyclinic University Hospital, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Matteo","family":"Ciccone","sequence":"additional","affiliation":[{"name":"University Cardiology Unit, Interdisciplinary Department of Medicine, Polyclinic University Hospital, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Maiello","sequence":"additional","affiliation":[{"name":"Cardiology Equipe, ASL Brindisi, 72100 Brindisi, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","article-title":"Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease","volume":"132","author":"Burnier","year":"2023","journal-title":"Circ. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.numecd.2020.08.028","article-title":"Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison","volume":"31","author":"Nardi","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/eurheartj\/ehaf167","article-title":"Cardiovascular disease in chronic kidney disease","volume":"46","author":"Cherney","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00059-024-05235-4","article-title":"Increased cardiovascular risk in patients with chronic kidney disease","volume":"49","author":"Vondenhoff","year":"2024","journal-title":"Herz"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database","volume":"13","author":"Heywood","year":"2007","journal-title":"J. Card. Fail."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/hr.2011.155","article-title":"Chronic kidney disease in postmenopausal women","volume":"35","author":"Suzuki","year":"2012","journal-title":"Hypertens. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"R498","DOI":"10.1152\/ajpregu.00182.2014","article-title":"Estrogen status and the renin angiotensin aldosterone system","volume":"307","author":"Floras","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jchf.2018.12.018","article-title":"Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome?","volume":"7","author":"Maslov","year":"2019","journal-title":"JACC Heart Fail."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000366455","article-title":"Left ventricular hypertrophy and chronic renal insufficiency in the elderly","volume":"4","author":"Leibowitz","year":"2014","journal-title":"Cardiorenal. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.echo.2021.12.003","article-title":"Associations between Myocardial Diastolic Dysfunction and Cardiovascular Mortality in Chronic Kidney Disease: A Large Single-Center Cohort Study","volume":"35","author":"Liang","year":"2022","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0735-1097(01)01450-4","article-title":"Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease","volume":"38","author":"Shlipak","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ahj.2014.12.010","article-title":"Mild renal dysfunction and long-term adverse outcomes in women with chest pain: Results from the National Heart, Lung, and Blood Institute-sponsored Women\u2019s Ischemia Syndrome Evaluation (WISE)","volume":"169","author":"Mohandas","year":"2015","journal-title":"Am. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCHEARTFAILURE.113.000952","article-title":"Fibroblast growth factor-23 and cardiovascular disease in the general population: The Multi-Ethnic Study of Atherosclerosis","volume":"7","author":"Kestenbaum","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Januzzi","year":"2009","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Coppi, F., Pagnoni, G., Grossule, F., Nassar, A., Maini, A., Masaracchia, G., Sbarra, F., Battigaglia, E., Maggio, E., and Aschieri, D. (2025). Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies. J. Cardiovasc. Dev. Dis., 12.","DOI":"10.3390\/jcdd12060213"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1016\/j.mayocp.2021.08.009","article-title":"The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy","volume":"96","author":"Gersh","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.CIR.95.1.39","article-title":"Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women","volume":"95","author":"Schunkert","year":"1997","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.atherosclerosis.2007.12.057","article-title":"Incident coronary artery calcium among postmenopausal women","volume":"200","author":"Kuller","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_23","first-page":"251","article-title":"Cardiorenal Syndrome: Pathophysiology","volume":"37","author":"Kumar","year":"2019","journal-title":"Cardiol. Clin."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10741-014-9460-9","article-title":"Chronic kidney disease and cardiovascular complications","volume":"20","author":"House","year":"2015","journal-title":"Heart Fail. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.5551\/jat.RV22006","article-title":"Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD","volume":"30","author":"Yamada","year":"2023","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41598-018-37690-5","article-title":"Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212","volume":"9","author":"Zvara","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.34067\/KID.0000000846","article-title":"Cardiovascular Risk after Renal Transplantation: Rejection as On-Going Risk Factor","volume":"6","author":"Torres","year":"2025","journal-title":"Kidney360"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Leifheit-Nestler, M., and Haffner, D. (2018). Paracrine Effects of FGF23 on the Heart. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00278"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/2895\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:20:40Z","timestamp":1775823640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/2895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["jcm15082895"],"URL":"https:\/\/doi.org\/10.3390\/jcm15082895","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]}}}